John Chiminski
Chair and Chief Executive Officer at Catalent Pharma Solutions
Meet John Chiminski
In the more than 20 years Chiminski has spent at Catalent, he has overseen the company’s strategy to help accelerate the small molecule development process and improve clinical outcomes. “We want to power the innovation and growth of the life science industry by becoming its leading development and commercial partner. To do that, we have built our team and capabilities to be in the best position to help innovators with development expertise, delivery technologies, and the right-scale manufacturing platforms to bring more of these programs to patients.”